Systemic amyloidosis is defined as a protein misfolding disease in which the amyloid is not necessarily deposited within the same organ that produces the fibril precursor protein. There are different types of systemic amyloidosis, depending on the protein constructing the fibrils. This review will focus on recent advances made in the understanding of the structural basis of three major forms of systemic amyloidosis: systemic AA, AL and ATTR amyloidosis. The three diseases arise from the misfolding of serum amyloid A protein, immunoglobulin light chains or transthyretin. The presented advances in understanding were enabled by recent progress in the methodology available to study amyloid structures and protein misfolding, in particular concerning cryo-electron microscopy (cryo-EM) and nuclear magnetic resonance (NMR) spectroscopy. An important observation made with these techniques is that the structures of previously described in vitro formed amyloid fibrils did not correlate with the structures of amyloid fibrils extracted from diseased tissue, and that in vitro fibrils were typically more protease sensitive. It is thus possible that ex vivo fibrils were selected in vivo by their proteolytic stability.
-
Cover Image
Cover Image
The cover image is an illustrative representation of chloroplast ATP synthases in a thylakoid membrane. In photosynthetic organisms the rotor complex of the ATP synthase (blue and cyan) is specifically adapted to physiological needs of the plant or cyanobacterial cell. For more details, see the review by Cheuk and Meier (pages 541–550). The figure was made by Anthony Cheuk.
Methods to study the structure of misfolded protein states in systemic amyloidosis Available to Purchase
Marcus Fändrich, Matthias Schmidt; Methods to study the structure of misfolded protein states in systemic amyloidosis. Biochem Soc Trans 30 April 2021; 49 (2): 977–985. doi: https://doi.org/10.1042/BST20201022
Download citation file:
Sign in
Sign in to your personal account
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Get Email Alerts
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |